99 related articles for article (PubMed ID: 12442393)
21. Time-dependent events in natural history of occult hepatitis B virus infection: the importance of population-based long-term follow-up study with repeated measurements.
Chen CJ
J Hepatol; 2005 Apr; 42(4):438-40. PubMed ID: 15763321
[No Abstract] [Full Text] [Related]
22. [Serological markers of hepatitis B virus].
Daikoku M; Yano M
Nihon Rinsho; 1999 Nov; 57 Suppl():344-6. PubMed ID: 10635852
[No Abstract] [Full Text] [Related]
23. [A case of repeated seroconversion to HBe antibody due to co-infection with Mutant- and wild-type hepatitis B virus clones].
Yukimasa N; Matsuda R; Yoneyama K; Takagi Y; Gomi K
Rinsho Byori; 2006 Jan; 54(1):31-5. PubMed ID: 16499227
[TBL] [Abstract][Full Text] [Related]
24. [Management of asymptomatic HBV carriers].
Yoshida H
Nihon Rinsho; 2004 Aug; 62 Suppl 8():238-41. PubMed ID: 15453322
[No Abstract] [Full Text] [Related]
25. A case-control study for early prediction of hepatitis B e antigen seroconversion by hepatitis B virus DNA levels and mutations in the precore region and core promoter.
Yamaura T; Tanaka E; Matsumoto A; Rokuhara A; Orii K; Yoshizawa K; Miyakawa Y; Kiyosawa K
J Med Virol; 2003 Aug; 70(4):545-52. PubMed ID: 12794716
[TBL] [Abstract][Full Text] [Related]
26. Serum hepatitis B virus DNA: relationship with the e-antigen and anti-e status in chronic carriers.
Yap SF; Wong NW; Goh KL
Malays J Pathol; 1994 Jun; 16(1):57-62. PubMed ID: 16329577
[TBL] [Abstract][Full Text] [Related]
27. Hepatitis B virus infection--natural history and clinical consequences.
Ganem D; Prince AM
N Engl J Med; 2004 Mar; 350(11):1118-29. PubMed ID: 15014185
[No Abstract] [Full Text] [Related]
28. Low frequency of precore mutants in anti-hepatitis B e antigen positive subjects with chronic hepatitis B virus infection in Chennai, Southern India.
Shanmugam S; Velu V; Nandakumar S; Madhavan V; Shanmugasundaram U; Shankar EM; Murugavel KG; Balakrishnan P; Kumarasamy N; Solomon S; Thyagarajan SP
J Microbiol Biotechnol; 2008 Oct; 18(10):1722-8. PubMed ID: 18955826
[TBL] [Abstract][Full Text] [Related]
29. Comparison of the Abbott Architect i2000 assay, the Roche Modular Analytics E170 assay, and an immunoradiometric assay for serum hepatitis B virus markers.
Kim H; Oh EJ; Kang MS; Kim SH; Park YJ
Ann Clin Lab Sci; 2007; 37(3):256-9. PubMed ID: 17709690
[TBL] [Abstract][Full Text] [Related]
30. Clinical significance of hepatitis B markers.
Lodenyo H
Trop Gastroenterol; 2000; 21(1):12-3. PubMed ID: 10835953
[No Abstract] [Full Text] [Related]
31. [Precore region mutation in anti-HBe antibody positive asymptomatic healthy carriers].
Fukuda R
Nihon Rinsho; 1995 Oct; 53 Suppl(Pt 2):189-94. PubMed ID: 12442384
[No Abstract] [Full Text] [Related]
32. [Mechanisms of hepatitis B e antigen seroconversion from the aspect of viral mutation].
Torii N; Hasegawa K; Oomori K; Shiratori K
Nihon Rinsho; 2004 Aug; 62 Suppl 8():93-7. PubMed ID: 15453294
[No Abstract] [Full Text] [Related]
33. Chronic hepatitis B e antigen (HBeAg) negative, anti-HBe positive hepatitis B: an overview.
Bonino F; Brunetto MR
J Hepatol; 2003; 39 Suppl 1():S160-3. PubMed ID: 14708696
[No Abstract] [Full Text] [Related]
34. Precore stop mutant in anti-HBe-positive phases of chronic hepatitis B virus infection.
Chu CM
Am J Gastroenterol; 2002 Aug; 97(8):2138-9; author reply 2139-40. PubMed ID: 12190193
[No Abstract] [Full Text] [Related]
35. In vitro production of antibody to hepatitis B core and E antigens by peripheral blood mononuclear cells in patients with chronic hepatitis B virus infection.
Tsutsumi Y; Kakumu S; Wakita T; Yoshioka K; Ishikawa T
J Immunol; 1990 Mar; 144(6):2389-93. PubMed ID: 2313098
[TBL] [Abstract][Full Text] [Related]
36. [Titers of selected indicators of hepatitis B in the blood of patients with acute viral hepatitis].
Rzeszowska G; Mazurek E; Mierzejewska I; Fijałka-Rymar M; Ignaciuk A
Ann Univ Mariae Curie Sklodowska Med; 1987; 42():89-94. PubMed ID: 3154901
[No Abstract] [Full Text] [Related]
37. Level of hepatitis B virus DNA in inactive carriers with persistently normal levels of alanine aminotransferase.
Chu CM; Chen YC; Tai DI; Liaw YF
Clin Gastroenterol Hepatol; 2010 Jun; 8(6):535-40. PubMed ID: 20304099
[TBL] [Abstract][Full Text] [Related]
38. Clinical, biochemical, immunological and virological profiles of, and differential diagnosis between, patients with acute hepatitis B and chronic hepatitis B with acute flare.
Han Y; Tang Q; Zhu W; Zhang X; You L
J Gastroenterol Hepatol; 2008 Nov; 23(11):1728-33. PubMed ID: 18823435
[TBL] [Abstract][Full Text] [Related]
39. The prevalence of hepatitis Be antigen and anti-HBE in adults in Benin City.
Abiodun PO; Olomu A; Okolo SN; Obasohan A; Freeman O
West Afr J Med; 1994; 13(3):171-4. PubMed ID: 7841109
[TBL] [Abstract][Full Text] [Related]
40. [Explanation of hepatitis B virus markers after hepatitis B vaccines inoculation].
Chen H; Zhu QR
Zhonghua Gan Zang Bing Za Zhi; 2003 Apr; 11(4):240. PubMed ID: 12716528
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
